Literature DB >> 7513117

[After-care in colorectal cancer--data and patient oriented evaluation].

J M Müller1, D Tübergen, U Zieren.   

Abstract

The results and the costs of a routine follow-up program for patients with curatively resected colo-rectal carcinoma were evaluated in a retrospective matched pair study. Patients, who never had participated in such a program, were used as controls. In addition 58 patients were questioned prospectively regarding their opinion about the value of the follow-up program for their present and future life. Significantly more local recurrences and distant metastases were diagnosed at an average of 1.5 years earlier in the follow-up group as compared with the control group. Neither the hereby resulting higher number of curatively resected local recurrences or distal metastases nor a more aggressive oncological approach in unresectable cases resulted in a substantial improvement of survival time in the follow-up group. Considering the relatively high costs of the program, only the diagnosis of several other illnesses which one was able to treat, and the high appreciation by the patients speak in favor of the follow-up program. 86.2% of the patients believed that routine follow-up would be of essential value for their future life.

Entities:  

Mesh:

Year:  1994        PMID: 7513117

Source DB:  PubMed          Journal:  Zentralbl Chir        ISSN: 0044-409X            Impact factor:   0.942


  2 in total

1.  Clinicopathologic factors affecting recurrence after curative surgery for stage I colorectal cancer.

Authors:  Min Ae Keum; Seok-Byung Lim; Sun A Kim; Yong Sik Yoon; Chan Wook Kim; Chang Sik Yu; Jin Cheon Kim
Journal:  J Korean Soc Coloproctol       Date:  2012-02-29

2.  Results of long-term follow-up after curative resection of Dukes A colorectal cancer.

Authors:  Matthias W Wichmann; Christian Müller; Hans M Hornung; Ulla Lau-Werner; Friedrich-Wilhelm Schildberg
Journal:  World J Surg       Date:  2002-03-26       Impact factor: 3.352

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.